Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
Vaccine X ; 18: 100490, 2024 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-38699156

RESUMO

Objective: Successful clinical conversations about vaccination in pregnancy (pertussis, COVID-19, and influenza) are key to improving low uptake rates of both vaccination in pregnancy and infancy. The purpose of this study was to understand Canadian perinatal care providers' knowledge, attitudes, and practices around vaccination in pregnancy. Methods: Qualitative interviews with 49 perinatal care providers (nurse practitioner, general practitioner, registered nurse, registered midwife, obstetrician-gynecologist, and family physicians) in 6 of 13 provinces and territories were deductively coded using directed content analysis [1] and analyzed according to key themes. Results: Participants detailed their professional training and experiences, patient community demographics, knowledge of vaccines, views and beliefs about vaccination in pregnancy, and attitudes about vaccine counselling. Providers generally described having a good range of information sources to keep vaccine knowledge up to date. Some providers lacked the necessary logistical setups to administer vaccines within their practice. Responses suggest diverging approaches to vaccine counselling. With merely hesitant patients, some opted to dig in and have more in-depth discussions, while others felt the likelihood of persuading an outright vaccine-refusing patient to vaccinate was too low to be worthwhile. Conclusion: Provider knowledge, attitudes, and practices around vaccination varied by professional background. To support perinatal providers' knowledge and practices, clinical guidelines should detail the importance of vaccination relative to other care priorities, emphasize the positive impact of engaging hesitant patients in vaccine counselling.

2.
Hum Vaccin Immunother ; 20(1): 2326779, 2024 Dec 31.
Artigo em Inglês | MEDLINE | ID: mdl-38517252

RESUMO

Despite the availability of school-based immunization programs (SBIPs) in Canada, human papillomavirus (HPV) vaccine uptake remains suboptimal. Vaccine education may improve vaccine uptake among adolescents. The objective of this qualitative study was to identify opportunities for HPV vaccine education in British Columbia, Canada, by exploring the perspectives of students, parents, school staff, and public health nurses on the current SBIP. Individual semi-structured interviews were conducted with adult participants and focus groups were conducted with grade 6 students between November 2019 and May 2020. The interviews and focus groups were transcribed and then analyzed using reflexive thematic analysis. Opportunities for HPV vaccine education were identified in three themes: 1) making SBIPs student-centered; 2) adopting a collaborative and interdisciplinary approach to vaccine education; and 3) actualizing parent education opportunities. Broad support existed for a formal, collaborative HPV grade 6 vaccine curriculum delivered by teachers and public health nurses to provide evidence-based health information. Participants voiced that the curriculum should integrate students' perspectives on topics of interest and address needle associated pain and anxiety. Parents were identified as the primary vaccine decisionmakers, therefore, participants stated it was crucial to also provide parent-directed vaccine education as part of SBIP. Our findings support the development of a collaborative HPV vaccine curriculum directed to and informed by students and parents to buttress current SBIPs in British Columbia.


Assuntos
Infecções por Papillomavirus , Vacinas contra Papillomavirus , Adulto , Adolescente , Humanos , Colúmbia Britânica , Infecções por Papillomavirus/prevenção & controle , Vacinação , Pais , Programas de Imunização , Aceitação pelo Paciente de Cuidados de Saúde , Conhecimentos, Atitudes e Prática em Saúde
3.
Pediatr Transplant ; 27(8): e14609, 2023 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-37746885

RESUMO

BACKGROUND: Live attenuated varicella vaccine (LAVV) has historically been contraindicated in children who are immunocompromised due to solid organ transplant (SOT) because of safety concerns. Recently, clinical guidelines were developed that support post-transplant varicella vaccination in selected SOT recipients based on emerging evidence of LAVV safety. This qualitative study sought to explore barriers and facilitators to implementing the new guidelines, as well as acceptability of LAVV among healthcare providers (HCPs) and parents. METHODS: HCPs and parents of transplant recipients were recruited from four sites using purposive sampling. Data from semi-structured interviews were analyzed using an Interpretive Description approach that incorporated data from the interviews, academic knowledge and clinical experience, and drew from Grounded Theory and Thematic Analysis. The theoretical framework used was Adaptive Leadership. RESULTS: Thirty-four participants (16 HCPs and 18 parents) were included in the analysis. Parents developed skills in adaptive leadership that included strategies to protect their child against infectious diseases. Foundational information that live vaccines were absolutely contraindicated post-transplant "stuck" with parents and led them to develop strategies other than vaccination to keep their child safe. Some parents struggled to understand that information previously presented as a certainty (contraindication of LAVV) could change. Their approach to adaptive leadership informed their appraisal of the new vaccination guidelines and willingness to accept vaccination. CONCLUSIONS: HCPs should adopt a family-centered approach to communicating changing guidelines that considers parents' approach to adaptive leadership and discusses the changing nature of medical evidence. Trust between HCPs and parents can facilitate these conversations.


Assuntos
Varicela , Transplante de Órgãos , Criança , Humanos , Varicela/prevenção & controle , Transplantados , Vacinação , Vacinas Atenuadas , Pessoal de Saúde , Pais
4.
PLoS One ; 18(7): e0288107, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37437041

RESUMO

OBJECTIVES: Teachers are an important occupational group to consider when addressing vaccine confidence and uptake for school-aged children due to their proximate role within school-based immunization programs. The objectives of this study were to characterize and identify sociodemographic factors associated with vaccine confidence and describe teachers' knowledge of and perceived role in the school-based immunization program, with the aim of informing public health policy and identifying opportunities for supporting teachers in their role in school-based immunization programs. METHODS: A cross-sectional survey of elementary and secondary public-school teachers in British Columbia was completed from August to November 2020. Respondents provided sociodemographic information, as well as past vaccination experience, vaccine knowledge, and perceived role in the school-based immunization program. Vaccine confidence was measured using the Vaccine Hesitancy Scale (VHS). Characteristics associated with the VHS sub-scales 'lack of confidence in vaccines' and 'perceived risk of vaccines', were explored using ANOVA. Descriptive analysis was completed for teachers' perceived role in the immunization program. RESULTS: 5,095 surveys were included in this analysis. Overall vaccine confidence was high, with vaccine hesitancy being related to the perceived risk of vaccines rather than a lack of confidence in the effectiveness of vaccines. ANOVA found significant differences for both VHS-sub-scales based on sociodemographic factors, however, the strength of the association was generally small. High general vaccine knowledge and never having delayed or refused a vaccine in the past were associated with higher vaccine confidence. Overall, teachers reported a lack of clarity in their role within the school-based immunization program. CONCLUSIONS: This large population-based observational study of teachers highlights a number of key engagement opportunities between public health and the education sector. Using a validated scale, we found that overall, teachers are highly accepting of vaccines, and well situated as potential partners with public health to address vaccine hesitancy.


Assuntos
Pessoal de Educação , Vacinas , Criança , Humanos , Colúmbia Britânica , Estudos Transversais , Coleta de Dados
5.
Artigo em Inglês | MEDLINE | ID: mdl-37008577

RESUMO

Background: Candidemia represents a significant cause of morbidity and mortality in children. We examined the epidemiology and associated risk factors of candidemia at a Canadian tertiary care paediatric hospital over an 11-year period. Methods: A retrospective chart review was conducted on children with positive blood culture for Candida species between January 1, 2007 and December 31, 2018. Patient demographics, previously described candidemia risk factors, Candida species, follow-up investigations, interventions, and outcome data were included in the analysis. Results: Sixty-one candidemia episodes were reported with an overall incidence rate of 5.1 cases per 10,000 patient admissions. Of the 66 species identified, the most common was Candida albicans (53%, 35), followed by Candida parapsilosis (18%, 12), and Candida glabrata (8%, 5). Mixed candidemia was noted in 8% (5/61) of episodes. The most common risk factors included presence of central venous catheter (95%, 58/61) and receipt of antibiotics in the last 30 days (92%, 56/61). Majority of patients received abdominal imaging (89%, 54/61), ophthalmology consult (84%, 51/61), and echocardiogram (70%, 43/61), regardless of age. Line removal was performed in 81% (47/58) of cases. Evidence of disseminated fungal disease on abdominal imaging was observed in 11% (6/54) of patients, all in non-neonates but with risk factors including immunosuppression and gastrointestinal abnormalities. The overall 30-day case fatality rate was 8% (5/61). Conclusions: C. albicans was the most commonly isolated species. Disseminated candidiasis was demonstrated mainly on abdominal imaging in patients with relevant risk factors, including immunosuppression and gastrointestinal abnormalities.


Historique: La candidémie est une cause importante de morbidité et de mortalité chez les enfants. Sur une période de 11 ans, les chercheurs ont examiné l'épidémiologie de la candidémie et les facteurs de risque s'y rapportant dans un hôpital pédiatrique canadien de soins tertiaires. Méthodologie: Les chercheurs ont procédé à une étude rétrospective des dossiers chez des enfants ayant reçu une culture sanguine positive à des espèces de Candida entre le 1er janvier 2007 et le 31 décembre 2018. Ils ont inclus dans l'analyse les caractéristiques démographiques des patients, les facteurs de risque de candidémie décrits auparavant, les espèces de Candida, les examens de suivi, les interventions et les données sur les résultats cliniques. Résultats: Au total, les chercheurs ont relevé 61 épisodes de candidémie, pour une incidence globale de 5,1 cas sur 10 000 admissions de patients. Ils ont constaté que les espèces les plus fréquentes (n = 66) étaient le Candida albicans (53%, n = 35), suivi du Candida parapsilosis (18%, n = 12) et du Candida glabrata (8%, n = 5), ainsi qu'une candidémie mixte dans 8% des épisodes (cinq sur 61). Les principaux facteurs de risque incluaient la présence d'un cathéter veineux central (95%, 58 cas sur 61) et l'administration d'antibiotiques dans les 30 jours précédents (92%, 56 cas sur 61). La majorité des patients se sont soumis à une imagerie abdominale (89%, 54 sur 61), à une consultation en ophtalmologie (84%, 51 sur 61) et à un échocardiogramme (70%, 43 sur 61), quel que soit leur âge. Leur cathéter a été retiré dans 81% des cas (47 cas sur 58). Les chercheurs ont constaté des manifestations d'infection fongique disséminée chez 11% des patients (six sur 54) à l'imagerie abdominale, soit chez aucun nouveau-né, mais chez des patients présentant des facteurs de risque comme une immunosuppression et des anomalies gastro-intestinales. Le taux de létalité global au bout de 30 jours s'élevait à 8% (cinq cas sur 61). Conclusions: Le C. albicans était l'espèce la plus souvent isolée. C'est surtout l'imagerie abdominale qui a démontré la présence d'une candidose disséminée, chez des patients ayant des facteurs de risque pertinents, y compris une immunosuppression et des anomalies gastro-intestinales.

6.
J Assoc Med Microbiol Infect Dis Can ; 7(2): 125-130, 2022 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-36337360

RESUMO

BACKGROUND: Non-tuberculous mycobacteria (NTM) are an uncommon but serious cause of peritoneal dialysis (PD)-related infections. NTM peritonitis typically necessitates PD catheter removal, PD withdrawal, and aggressive, prolonged antimicrobial treatment. Few reported cases of NTM peritonitis in the pediatric population exist. METHODS: We describe a case of a 9-year-old boy on PD after kidney allograft failure who developed Mycobacterium fortuitum peritonitis, and we summarize the available literature on M. fortuitum peritonitis in pediatric patients receiving PD. RESULTS AND CONCLUSION: Therapeutic options were limited by adverse medication effects and risk of drug-drug interactions in a patient with complex mental health comorbidities. Clofazimine presented an acceptable oral treatment option for long-term therapy in combination with ciprofloxacin and was well tolerated by this patient. Prompt PD catheter removal followed by 6 months of dual antimicrobial therapy resulted in a full recovery and successful re-transplantation with no infection relapse.


HISTORIQUE: Les mycobactéries non tuberculeuses (MNT) sont une cause courante, mais peu fréquente, d'infections causées par la dialyse péritonéale (DP). En général, la péritonite à MNT nécessite le retrait du cathéter à DP, le retrait de la DP et un traitement antimicrobien prolongé et énergique de la DP. Il y a quelques cas déclarés de péritonite à MNT dans la population pédiatrique. MÉTHODOLOGIE: Les auteurs décrivent le cas d'un garçon de neuf ans sous DP à cause de l'insuffisance d'une allogreffe rénale et qui est atteint d'une péritonite à Mycobacterium fortuitum, et ils résument le contenu des publications scientifiques sur la péritonite à M. fortuitum chez les patients pédiatriques sous DP. RÉSULTATS ET CONCLUSION: Les possibilités thérapeutiques étaient limitées par les effets indésirables des médicaments et le risque d'interactions entre médicaments chez un patient ayant des morbidités complexes en santé mentale. La clofazimine était un traitement par voie orale acceptable pour un traitement à long terme combiné avec de la ciprofloxacine et était bien tolérée. Le retrait rapide du cathéter à DP suivi par six mois de bithérapie antimicrobienne a permis une pleine guérison et une nouvelle transplantation réussie, sans récidive de l'infection.

7.
Vaccine ; 40(38): 5594-5600, 2022 09 09.
Artigo em Inglês | MEDLINE | ID: mdl-35989134

RESUMO

Uptake of vaccination during pregnancy in Canada is lower than comparator countries. A recommendation from a trusted perinatal healthcare provider is a key opportunity to promote vaccine uptake and improve confidence. This study aims to identify barriers and opportunities to vaccination in midwifery care. Seventeen semi-structured telephone interviews with practicing midwives, educators and public health professionals with immunization training experiences were conducted. Documents pertaining to the midwifery profession (approx. 50) were reviewed. Inductive thematic analysis identified logistical, interprofessional, and information barriers preventing Canadian midwives from administering vaccines and counseling clients about vaccination, as well as opportunities to address each barrier. Key interventions at the level of logistics, training, and client information materials would help address barriers to the integration of midwives into the provision and recommendation of vaccines in perinatal care across Canada.


Assuntos
Vacinas contra Influenza , Tocologia , Canadá , Feminino , Conhecimentos, Atitudes e Prática em Saúde , Humanos , Gravidez , Vacinação/psicologia
8.
PLOS Glob Public Health ; 2(9): e0001109, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-36962668

RESUMO

Adolescence presents a key opportunity to build vaccine-related health literacy and promote vaccine confidence and uptake. Although adolescents are central to vaccination programs, their views around vaccines are frequently underrepresented in qualitative literature. We reviewed qualitative studies to systematically identify and summarize existing evidence on adolescents' own understanding of vaccines and experiences with vaccine decision-making, including self-consent when applicable. CINAHL; Embase; Ovid Medline; and Psych Info database searches were last updated on May 28, 2022. Data pertaining to general study characteristics, participant demographics, and qualitative content were extracted independently by two reviewers and analyzed using textual narrative synthesis. Out of 3559 individual records, 59 studies were included. The majority of the studies were conducted in high-income countries and 75% focused on human papilloma virus vaccines, with the remaining studies looking at COVID-19, meningococcal, hepatitis B and influenza vaccines or adolescent experiences with vaccines in general. Adolescent self-consent was explored in 7 studies. Perspectives from sexual and gender minorities were lacking across studies. Adolescents often had limited understanding of different vaccines and commonly perceived vaccine information to be directed towards their parents rather than themselves. Many adolescents felt school-based vaccine education and information available through healthcare providers were insufficient to make informed decisions about vaccines. While adolescents described obtaining vaccine information from traditional and online media, face-to-face interactions and opinions from trusted adults remained important. Adolescents generally relied on their parents for vaccine-decision making, even when self-consent was an option. A notable exception to this included marginalized adolescents who could not rely on parents for health-related advice. Qualitative literature about adolescent vaccines would be enriched by studies examining vaccines other than the HPV vaccine, studies examining adolescent vaccine programs in low and middle-income countries, and by deliberately eliciting vaccine experiences of adolescent with diverse sexual orientation and gender identities.

10.
Vaccine X ; 8: 100106, 2021 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-34222854

RESUMO

BACKGROUND: To control the COVID-19 pandemic high vaccine acceptability and uptake will be needed. Teachers represent a priority population to minimize social disruption and ensure continuity in education, which is vital for the well-being and healthy development of youth during the pandemic. The objective of this analysis was to measure public school teachers' intentions to receive a COVID-19 vaccine in British Columbia (BC), Canada. METHODS: A population-wide cross-sectional online survey from August to November 2020 asked all BC public school teachers with an available email address how likely they were to receive a COVID-19 vaccine. Two multivariable logistic regression models explored separately sociodemographic and vaccine hesitancy predictors for intention to receive a COVID-19 vaccine. RESULTS: A total of 5,076 teachers participated. The majority, 89.7%, reported they were likely or very likely to accept a COVID-19 vaccine. In multivariable regression, sociodemographic predictors of intention to be vaccinated included being male, having an educational background in science or engineering, and using reliable information sources on vaccination such as public health and health care providers. Teachers who reported lower levels of vaccine hesitancy, higher general vaccine knowledge, and belief that COVID-19 was a serious illness were more likely to intend to receive a COVID-19 vaccine. CONCLUSION: A high proportion of public-school teachers in BC intend to receive a COVID-19 vaccine. Continued monitoring of vaccine intentions will be important to inform public health vaccine implementation.

11.
Microorganisms ; 9(3)2021 Mar 05.
Artigo em Inglês | MEDLINE | ID: mdl-33807653

RESUMO

Bacterial meningitis is a devastating infection, with a case fatality rate of up to 30% and 50% of survivors developing neurological complications. These include short-term complications such as focal neurological deficit and subdural effusion, and long-term complications such as hearing loss, seizures, cognitive impairment and hydrocephalus. Complications develop due to bacterial toxin release and the host immune response, which lead to neuronal damage. Factors associated with increased risk of developing neurological complications include young age, delayed presentation and Streptococcus pneumoniae as an etiologic agent. Vaccination is the primary method of preventing bacterial meningitis and therefore its complications. There are three vaccine preventable causes: Haemophilus influenzae type b (Hib), S. pneumoniae, and Neisseria meningitidis. Starting antibiotics without delay is also critical to reduce the risk of neurological complications. Additionally, early adjuvant corticosteroid use in Hib meningitis reduces the risk of hearing loss and severe neurological complications.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...